AXA S.A. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$864,000
-69.6%
15,200
-59.9%
0.00%
-88.9%
Q1 2021$2,838,000
-74.2%
37,919
-70.2%
0.01%
-74.3%
Q4 2020$11,004,000
+39.2%
127,195
-1.7%
0.04%
+20.7%
Q3 2020$7,908,000
-57.4%
129,377
-71.0%
0.03%
-21.6%
Q2 2020$18,568,000
+627.0%
446,544
+402.3%
0.04%
+516.7%
Q1 2020$2,554,000
-62.6%
88,902
-6.0%
0.01%
-57.1%
Q4 2019$6,826,000
-47.3%
94,554
+2.3%
0.01%
-46.2%
Q3 2019$12,962,000
-23.5%
92,394
-0.2%
0.03%
-21.2%
Q2 2019$16,946,000
+135.4%
92,558
+104.5%
0.03%
+17.9%
Q1 2019$7,200,000
+66.1%
45,2700.0%0.03%
+47.4%
Q4 2018$4,336,000
-55.9%
45,270
-34.9%
0.02%
-47.2%
Q3 2018$9,826,000
-9.9%
69,570
-0.1%
0.04%
-14.3%
Q2 2018$10,905,000
+7.5%
69,670
+10.6%
0.04%
+5.0%
Q1 2018$10,147,000
+36.5%
62,994
+39.6%
0.04%
+37.9%
Q4 2017$7,432,000
+156.7%
45,120
-2.9%
0.03%
+141.7%
Q3 2017$2,895,000
-20.6%
46,464
+1.5%
0.01%
-29.4%
Q2 2017$3,647,000
+8.0%
45,788
-3.6%
0.02%
+13.3%
Q1 2017$3,376,000
+34.9%
47,509
-3.0%
0.02%
+25.0%
Q4 2016$2,502,000
+13.0%
49,002
+1.9%
0.01%
+20.0%
Q3 2016$2,214,000
+53.0%
48,075
+0.1%
0.01%
+66.7%
Q2 2016$1,447,00048,0310.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders